• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

革兰阳性菌和革兰阴性菌中头孢洛林多步耐药发展研究。

Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.

机构信息

Department of Pathology, Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA.

出版信息

Antimicrob Agents Chemother. 2011 May;55(5):2344-51. doi: 10.1128/AAC.01602-10. Epub 2011 Feb 22.

DOI:10.1128/AAC.01602-10
PMID:21343467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3088212/
Abstract

Ceftaroline, the active component of the prodrug ceftaroline fosamil, is a novel broad-spectrum cephalosporin with bactericidal activity against Gram-positive and -negative isolates. This study evaluated the potential for ceftaroline and comparator antibiotics to select for clones of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Moraxella catarrhalis, Klebsiella pneumoniae, Staphylococcus aureus, and Enterococcus faecalis with elevated MICs. S. pneumoniae and S. pyogenes isolates in the present study were highly susceptible to ceftaroline (MIC range, 0.004 to 0.25 μg/ml). No streptococcal strains yielded ceftaroline clones with increased MICs (defined as an increase in MIC of >4-fold) after 50 daily passages. Ceftaroline MICs for H. influenzae and M. catarrhalis were 0.06 to 2 μg/ml for four strains and 8 μg/ml for a β-lactamase-positive, efflux-positive H. influenzae with a mutation in L22. One H. influenzae clone with an increased ceftaroline MIC (quinolone-resistant, β-lactamase-positive) was recovered after 20 days. The ceftaroline MIC for this isolate increased 16-fold, from 0.06 to 1 μg/ml. MICs for S. aureus ranged from 0.25 to 1 μg/ml. No S. aureus isolates tested with ceftaroline had clones with increased MIC (>4-fold) after 50 passages. Two E. faecalis isolates tested had ceftaroline MICs increased from 1 to 8 μg/ml after 38 days and from 4 to 32 μg/ml after 41 days, respectively. The parental ceftaroline MIC for the one K. pneumoniae extended-spectrum β-lactamase-negative isolate tested was 0.5 μg/ml and did not change after 50 daily passages.

摘要

头孢洛林是前体药物头孢洛林磷酸酯的活性成分,是一种新型的广谱头孢菌素,对革兰氏阳性和革兰氏阴性分离株具有杀菌活性。本研究评估了头孢洛林和对照抗生素选择肺炎链球菌、化脓性链球菌、流感嗜血杆菌、卡他莫拉菌、肺炎克雷伯菌、金黄色葡萄球菌和粪肠球菌的克隆的潜力,这些克隆对药物的 MIC 值升高。本研究中的肺炎链球菌和化脓性链球菌分离株对头孢洛林高度敏感(MIC 范围为 0.004 至 0.25 μg/ml)。经过 50 天的连续传代,没有链球菌菌株产生头孢洛林的耐药克隆(定义为 MIC 增加>4 倍)。四种流感嗜血杆菌和卡他莫拉菌的头孢洛林 MIC 为 0.06 至 2 μg/ml,而β-内酰胺酶阳性、外排阳性、L22 突变的流感嗜血杆菌的 MIC 为 8 μg/ml。经过 20 天,恢复了一个具有增加的头孢洛林 MIC 的流感嗜血杆菌克隆(耐喹诺酮、β-内酰胺酶阳性)。该分离株的头孢洛林 MIC 增加了 16 倍,从 0.06 增加至 1 μg/ml。金黄色葡萄球菌的 MIC 范围为 0.25 至 1 μg/ml。经过 50 天的传代,没有测试的金黄色葡萄球菌分离株具有增加的 MIC (>4 倍)的克隆。经过 38 天和 41 天,两种粪肠球菌的头孢洛林 MIC 分别从 1 增加到 8 μg/ml 和从 4 增加到 32 μg/ml。一个测试的产超广谱β-内酰胺酶阴性肺炎克雷伯菌的头孢洛林母本 MIC 为 0.5 μg/ml,经过 50 天的连续传代,MIC 值没有变化。

相似文献

1
Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.革兰阳性菌和革兰阴性菌中头孢洛林多步耐药发展研究。
Antimicrob Agents Chemother. 2011 May;55(5):2344-51. doi: 10.1128/AAC.01602-10. Epub 2011 Feb 22.
2
AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.AWARE 头孢洛林监测计划(2008-2010 年):美国肺炎链球菌、流感嗜血杆菌和卡他莫拉菌耐药模式的趋势。
Clin Infect Dis. 2012 Sep;55 Suppl 3:S187-93. doi: 10.1093/cid/cis561.
3
In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.2009 年加拿大医院分离的革兰阳性和革兰阴性病原菌的体外 ceftaroline 活性。
Antimicrob Agents Chemother. 2011 Jun;55(6):2837-46. doi: 10.1128/AAC.01787-10. Epub 2011 Mar 14.
4
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.2010 年至 2012 年加拿大医院分离的革兰阴性和革兰阳性病原菌的体外研究:来自 CANWARD 监测研究的结果。
Antimicrob Agents Chemother. 2013 Nov;57(11):5600-11. doi: 10.1128/AAC.01485-13. Epub 2013 Aug 26.
5
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).检测亚太地区和南非分离的致皮肤软组织感染和社区获得性呼吸道感染的细菌分离株的抗菌活性:头孢洛林和比较剂(2010 年)。
Diagn Microbiol Infect Dis. 2013 May;76(1):61-8. doi: 10.1016/j.diagmicrobio.2013.01.005. Epub 2013 Mar 25.
6
Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.比较头孢洛林对与社区获得性肺炎相关病原体的活性:一项国际监测研究的结果。
J Antimicrob Chemother. 2011 Apr;66 Suppl 3:iii69-80. doi: 10.1093/jac/dkr101.
7
In vitro susceptibility of ceftaroline against clinically important Gram-positive cocci, Haemophilus species and Klebsiella pneumoniae in Taiwan: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018.在台湾,2012-2018 年抗微生物药物检测领导和监测(ATLAS)研究中头孢洛林对临床重要的革兰阳性球菌、嗜血杆菌属和肺炎克雷伯菌的体外药敏结果。
J Microbiol Immunol Infect. 2021 Aug;54(4):627-631. doi: 10.1016/j.jmii.2020.04.017. Epub 2020 May 11.
8
Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program.美国 2010 年头孢洛林针对病原体的活性总结:来自评估全球抗菌药物耐药性监测(AWARE)计划的报告。
Antimicrob Agents Chemother. 2012 Jun;56(6):2933-40. doi: 10.1128/AAC.00330-12. Epub 2012 Apr 2.
9
Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).头孢洛林针对儿科患者分离出的细菌的活性测试:来自美国全球抗菌药物耐药性评估与评价项目(2011 - 2012年)的结果。
Pediatr Infect Dis J. 2014 Aug;33(8):837-42. doi: 10.1097/INF.0000000000000307.
10
Comparative analysis of the antibacterial activity of a novel peptide deformylase inhibitor, GSK1322322.新型肽酰基转移酶抑制剂 GSK1322322 的抗菌活性比较分析。
Antimicrob Agents Chemother. 2013 May;57(5):2333-42. doi: 10.1128/AAC.02566-12. Epub 2013 Mar 11.

引用本文的文献

1
Antibacterial Activity of Co(III) Complexes with Diamine Chelate Ligands against a Broad Spectrum of Bacteria with a DNA Interaction Mechanism.具有二胺螯合配体的钴(III)配合物对多种细菌的抗菌活性及DNA相互作用机制
Pharmaceutics. 2021 Jun 24;13(7):946. doi: 10.3390/pharmaceutics13070946.
2
New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics.用于治疗儿科急性细菌性皮肤和软组织感染的新型抗生素
Pharmaceuticals (Basel). 2020 Oct 23;13(11):333. doi: 10.3390/ph13110333.
3
Ceftaroline Fosamil as an Alternative for a Severe Methicillin-resistant Staphylococcus aureus Infection: A Case Report.头孢洛林酯作为耐甲氧西林金黄色葡萄球菌严重感染的替代治疗药物:一例报告
Cureus. 2018 Dec 25;10(12):e3776. doi: 10.7759/cureus.3776.
4
Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.头孢洛林酯在儿童中的应用:当前知识综述及其应用
Infect Dis Ther. 2017 Mar;6(1):57-67. doi: 10.1007/s40121-016-0144-8. Epub 2016 Dec 30.
5
Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.头孢替唑肟酯:在复杂性皮肤和软组织感染及社区获得性肺炎中的应用评价。
Drugs. 2016 Nov;76(17):1659-1674. doi: 10.1007/s40265-016-0654-4.
6
Study of Antibiotic Resistance Pattern in Methicillin Resistant Staphylococcus Aureus with Special Reference to Newer Antibiotic.耐甲氧西林金黄色葡萄球菌抗生素耐药模式的研究,特别涉及新型抗生素
J Glob Infect Dis. 2015 Apr-Jun;7(2):78-84. doi: 10.4103/0974-777X.157245.
7
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.革兰氏阴性菌中由外排介导的抗生素耐药性挑战。
Clin Microbiol Rev. 2015 Apr;28(2):337-418. doi: 10.1128/CMR.00117-14.
8
Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.1998年以来存档于瑞士西部的医院流行获得性耐甲氧西林金黄色葡萄球菌克隆型ST228和ST247中检测到影响头孢洛林敏感性的PBP2A错义突变。
Antimicrob Agents Chemother. 2015 Apr;59(4):1922-30. doi: 10.1128/AAC.04068-14. Epub 2015 Jan 12.
9
Ceftaroline fosamil: a brief clinical review.头孢替唑钠:简要临床评价。
Infect Dis Ther. 2013 Dec;2(2):95-110. doi: 10.1007/s40121-013-0010-x. Epub 2013 Aug 8.
10
[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].[革兰氏阳性球菌对“最后手段”抗生素的耐药性:万古霉素后时代]
Biomedica. 2014 Apr;34 Suppl 1(0 1):191-208. doi: 10.1590/S0120-41572014000500022.

本文引用的文献

1
Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents.微生物耐药决定因素与抗革兰阳性药物的流行病学和临床相关性。
Curr Opin Microbiol. 2010 Oct;13(5):582-8. doi: 10.1016/j.mib.2010.08.006. Epub 2010 Sep 16.
2
Tigecycline - how powerful is it in the fight against antibiotic-resistant bacteria?替加环素——在对抗抗生素耐药菌方面有多强大?
Medicina (Kaunas). 2010;46(4):240-8.
3
Polyphyletic emergence of linezolid-resistant staphylococci in the United States.美国利奈唑胺耐药葡萄球菌的多系起源。
Antimicrob Agents Chemother. 2010 Feb;54(2):742-8. doi: 10.1128/AAC.00621-09. Epub 2009 Nov 23.
4
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.CEM-101 对具有明确大环内酯类耐药机制的肺炎链球菌和化脓性链球菌的体外活性。
Antimicrob Agents Chemother. 2010 Jan;54(1):230-8. doi: 10.1128/AAC.01123-09. Epub 2009 Nov 2.
5
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.核糖体蛋白 L3 中的突变与临床来源的葡萄球菌对唑烷酮类药物的耐药性有关。
Antimicrob Agents Chemother. 2009 Dec;53(12):5275-8. doi: 10.1128/AAC.01032-09. Epub 2009 Oct 5.
6
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia.严重社区获得性耐甲氧西林金黄色葡萄球菌肺炎患者的发病情况、特征和结局。
Eur Respir J. 2009 Nov;34(5):1148-58. doi: 10.1183/09031936.00041009. Epub 2009 Jun 18.
7
Comparative antipneumococcal activities of sulopenem and other drugs.舒洛培南与其他药物的抗肺炎球菌活性比较。
Antimicrob Agents Chemother. 2009 Jun;53(6):2239-47. doi: 10.1128/AAC.01531-08. Epub 2009 Mar 23.
8
Canadian beta-lactamase-negative Haemophilus influenzae isolates showing decreased susceptibility toward ampicillin have significant penicillin binding protein 3 mutations.对氨苄西林敏感性降低的加拿大β-内酰胺酶阴性流感嗜血杆菌分离株存在显著的青霉素结合蛋白3突变。
Diagn Microbiol Infect Dis. 2009 Apr;63(4):379-83. doi: 10.1016/j.diagmicrobio.2008.12.015. Epub 2009 Feb 26.
9
Ceftaroline: a cephalosporin with expanded Gram-positive activity.头孢洛林:一种具有扩大革兰氏阳性菌活性的头孢菌素。
Future Microbiol. 2009 Feb;4(1):25-33. doi: 10.2217/17460913.4.1.25.
10
Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.新型头孢菌素头孢洛林对社区获得性肺炎患者血培养分离菌的活性
Int J Antimicrob Agents. 2009 Jun;33(6):515-9. doi: 10.1016/j.ijantimicag.2008.12.005. Epub 2009 Feb 8.